1. Home
  2. >
  3. Business đź’Ľ
Posted

Major Retailers Sued Over Ineffective Decongestant Ingredients

  • Lawsuit filed in California seeks damages for consumers who bought over-the-counter decongestants containing phenylephrine, which was found ineffective.

  • At least 250 products contain phenylephrine, including name brands and generics from major retailers.

  • 14 retailers and drug companies named as defendants, including Walmart, CVS, Amazon, Target.

  • Lawsuit argues statute of limitations should start when FDA panel found phenylephrine ineffective earlier this week.

  • Plaintiffs seek payment for all who bought the products, plus corrective advertising campaign from companies.

mercurynews.com
Relevant topic timeline:
The FDA has concluded that phenylephrine, a common decongestant ingredient in over-the-counter cold and flu medications, is no more effective than a placebo, possibly leading to the removal of these medicines from shelves as manufacturers work to find alternative formulas.
Johnson & Johnson, Procter & Gamble, and Walgreens are facing lawsuits alleging that they misled consumers about the effectiveness of cold medicines containing phenylephrine, an ingredient declared ineffective by a unanimous U.S. FDA advisory panel.
Pharmaceutical company Eli Lilly has filed lawsuits against various US medical spas, wellness centers, and compounding pharmacies to prevent the "unlawful marketing and sale" of non-FDA approved compounded products that falsely claim to be its medication, Mounjaro, which treats Type 2 diabetes.
The Federal Trade Commission has filed an antitrust lawsuit against a doctors' group and a private equity firm, accusing them of consolidating doctors' groups in Texas to raise prices for anesthesia services and harm fair competition.
Over 200 over-the-counter decongestants containing phenylephrine, a key ingredient just revealed to be ineffective, are still on pharmacy shelves despite evidence dating back to 2007 showing that it doesn't work.